Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Total Current Liabilities (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 15 years of Total Current Liabilities data on record, last reported at $139.6 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 36.09% year-over-year to $139.6 million; the TTM value through Dec 2025 reached $139.6 million, up 36.09%, while the annual FY2025 figure was $106.6 million, 8.91% down from the prior year.
  • Total Current Liabilities reached $139.6 million in Q4 2025 per PBH's latest filing, up from $134.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $160.7 million in Q1 2023 and bottomed at $102.5 million in Q4 2024.
  • Average Total Current Liabilities over 5 years is $131.9 million, with a median of $132.2 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: fell 27.17% in 2024, then soared 36.09% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $135.1 million in 2021, then increased by 18.54% to $160.2 million in 2022, then dropped by 20.44% to $127.4 million in 2023, then fell by 19.53% to $102.5 million in 2024, then skyrocketed by 36.09% to $139.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $139.6 million in Q4 2025, $134.6 million in Q3 2025, and $109.7 million in Q2 2025.